Response to comments on "anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel" [3]

Authors

Deshi Shi, University of Rhode Island
Jian Yang, University of Rhode Island
Dongfang Yang, University of Rhode Island
Edward L. LeCluyse, CellzDirect, Inc.
Chris Black, CellzDirect, Inc.
Li You, University of Rhode Island
Fatemeh Akhlaghi, University of Rhode Island
Bingfang Yang, University of Rhode Island

Document Type

Letter to the Editor

Date of Original Version

7-1-2007

Publication Title, e.g., Journal

Journal of Pharmacology and Experimental Therapeutics

Volume

322

Issue

1

Citation/Publisher Attribution

Shi, Deshi, Jian Yang, Dongfang Yang, Edward L. LeCluyse, Chris Black, Li You, Fatemeh Akhlaghi, and Bingfang Yang. "Response to comments on "anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel" [3]." Journal of Pharmacology and Experimental Therapeutics 322, 1 (2007). doi: 10.1124/jpet.107.120030.